Kiran Syntex (530443)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Latest quarterly sales of ₹3 Cr provide a small revenue base against a ₹4 Cr market cap.
• Book value of ₹4.51 per share gives tangible asset backing, though the stock trades above it.
• As a ₹4 Cr microcap, even modest asset monetisation or operational improvement could move per-share value materially.

Concerns

• P/E is 0.00 and the latest quarter shows a net loss of ~₹0 Cr, so there is no current earnings support.
• ROE of -0.35% and ROCE of -3.86% show the company is destroying value on both equity and capital.
• At ₹8.15, the price is 1.81x book value ₹4.51, leaving no margin of safety for a loss-making business.
• Zero sales/profit growth, zero dividend, and undisclosed promoter holding make it an opaque, no-catalyst microcap.

AI Analysis

At ₹8.15, Kiran Syntex is a ₹4 crore microcap in textiles. The first thing I notice is the absence of earnings: P/E is 0.00, the latest quarter shows a net loss of about ₹0 crore, and returns are negative—ROE at -0.35%, ROCE at -3.86%. A business that cannot earn a positive return on equity or capital is destroying value, no matter how small it is. The Piotroski F-Score of 2 out of 9 reinforces that: profitability, leverage, and operating efficiency are all weak. What about the balance sheet? Book value is ₹4.51, but at ₹8.15 I am paying 1.81 times book. That is not a Graham-style margin of safety. There is zero dividend, zero sales growth, zero profit growth, and promoter holding is not disclosed. I cannot judge management quality or alignment. The 52-week range of ₹6.86 to ₹20.00 shows a stock that has lost more than half its value and remains volatile. One mild positive is that quarterly sales of ₹3 crore against a ₹4 crore market cap give the company some operating scale. But scale without profit is not value. For a value investor, the question is whether an asset or an earning power is being bought at a discount. Here, the market is paying a premium to book for a business earning negative returns. It might become a turnaround if operations improve, but that is speculation, not investment. I would need to see positive ROCE, a stable balance sheet, and evidence that assets are being deployed productively before I part with my capital. Until then, Kiran Syntex remains a watch-list candidate, not a holding.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer